Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation
- PMID: 10971390
- DOI: 10.1046/j.1365-2141.2000.02191.x
Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation
Abstract
A patient with Jo-1 antibody-associated polymyositis (Jo-1 PM) had a Karnofsky score of 40% and severe muscle, liver and lung damage that was refractory to standard therapy. The female patient received an autologous T-cell-depleted haematopoietic stem cell transplant (HSCT) after myeloablative conditioning. The transplant procedure was complicated by severe adult respiratory distress syndrome (ARDS) and adenovirus-associated haemorrhagic cystitis as well as cytomegalovirus (CMV) reactivation. The patient's creatinine phosphokinase (CPK) and alanine transaminase (ALT) values were normal on day 21. The patient's strength has improved remarkably and her dyspnoea is subjectively improved. At 15 months after the transplant, the patient was well with a Karnofsky score of 80% and had been off any therapy, including steroids, for 14 months.
Comment in
-
Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up.Br J Haematol. 2001 Jun;113(3):840-1. doi: 10.1046/j.1365-2141.2001.02804-2.x. Br J Haematol. 2001. PMID: 11380480 No abstract available.
Similar articles
-
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007).Mol Immunol. 2009 Nov;47(1):46-51. doi: 10.1016/j.molimm.2008.12.029. Epub 2009 Feb 8. Mol Immunol. 2009. PMID: 19203795 Clinical Trial.
-
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.Transpl Infect Dis. 2007 Dec;9(4):286-94. doi: 10.1111/j.1399-3062.2007.00235.x. Epub 2007 May 19. Transpl Infect Dis. 2007. PMID: 17511819
-
Adult respiratory distress syndrome in polymyositis patients with the anti-Jo-1 antibody.Arthritis Rheum. 1995 Oct;38(10):1519-23. doi: 10.1002/art.1780381020. Arthritis Rheum. 1995. PMID: 7575703
-
Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.Isr Med Assoc J. 2002 Nov;4(11 Suppl):865-7. Isr Med Assoc J. 2002. PMID: 12455162 Review. No abstract available.
-
Haematopoietic stem cell transplantation for autoimmune diseases.Nat Rev Rheumatol. 2017 Apr;13(4):244-256. doi: 10.1038/nrrheum.2017.7. Epub 2017 Feb 23. Nat Rev Rheumatol. 2017. PMID: 28228650 Review.
Cited by
-
Idiopathic inflammatory myopathies: a treatment update.Curr Rheumatol Rep. 2003 Dec;5(6):431-6. doi: 10.1007/s11926-003-0053-1. Curr Rheumatol Rep. 2003. PMID: 14609487 Review.
-
Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies.Biosci Rep. 2023 Jan 31;43(1):BSR20220284. doi: 10.1042/BSR20220284. Biosci Rep. 2023. PMID: 36538023 Free PMC article. Review.
-
Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Clin Rev Allergy Immunol. 2017 Feb;52(1):34-44. doi: 10.1007/s12016-015-8512-9. Clin Rev Allergy Immunol. 2017. PMID: 26429707 Review.
-
Stromal vascular fraction in the treatment of myositis.Cell Death Discov. 2023 Sep 19;9(1):346. doi: 10.1038/s41420-023-01605-9. Cell Death Discov. 2023. PMID: 37726262 Free PMC article. Review.
-
Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?Int J Hematol. 2002 Aug;76 Suppl 1:226-47. doi: 10.1007/BF03165251. Int J Hematol. 2002. PMID: 12430858 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical